3,019
Views
14
CrossRef citations to date
0
Altmetric
Review

Vaccination in people with disability: a review

, , , &
Pages 7-15 | Received 28 Apr 2019, Accepted 27 Jun 2019, Published online: 24 Jul 2019

ABSTRACT

People with disabilities are vulnerable to complications from vaccine-preventable diseases, and every effort should be made to ensure equitable access to immunization for this population. This paper aims to summarize the research on immunizations in people with disabilities, in order to ensure a comprehensive understanding of knowledge in this area and direct further research. The literature is weighted towards coverage data that is difficult to synthesize because of the different definitions of disability, and the variety of settings, vaccinations and age groups across the studies. In-depth qualitative data and data from a variety of health-care providers and people with disability is notably lacking. This is vital to redress in order to develop effective immunization interventions in this population.

Immunization is arguably the most successful public health initiative of all time,Citation1 through prevention of death and reduction in disease severity, complications, and disability. Effective immunization programs also improve health equity for vulnerable groups in society who have a higher burden of vaccine-preventable diseases (VPDs).Citation1,Citation2 However, there appears to be a disconnect in identifying the need for the prevention of disability by immunization against VPDs and efforts to ensure optimal protection in those with existing disability. Underlying disability, particularly physical disability or disability related to prematurity, predisposes an individual to respiratory illness and more severe respiratory compromise from viral and bacterial infections.Citation3 Disability is as a factor in a disproportionate number of hospitalizations and complications, including death, from varicellaCitation4 and influenza.Citation5Citation10

The Tailoring Immunization Program (TIP) framework, developed by the World Health Organization (WHO), identifies barriers to immunization in under-vaccinated populations.Citation11,Citation12 This approach has been used in migrant and transient populations, orthodox Jewish communities, and pregnant women, leading to targeted interventions to improve uptake for these groups. However, unlike other vulnerable and medically at-risk groups, strategies to improve vaccine uptake in people with physical and/or intellectual disabilities, who face considerable access and acceptance barriers, have not been explored. This literature review aims to summarize the state of knowledge about vaccination in people with disability, in order to establish this group as a population vulnerable to under-immunization and to identify areas for further research and intervention.

Definitions of disability

The International Classification of Functioning, Disability, and Health (ICF) is a broad measure of disability based on impairments of body function, activity limitations and participation restrictions.Citation13 Data from WHO suggest that 15% of the world’s population has some impairment in function, with 2–4% having significant difficulties with activities of daily living.Citation14 This includes those with disability due to aging, mental illness, trauma, and chronic illness as well as those with physical and intellectual disabilities diagnosed early in life.

The ICF classification incorporates environmental factors that impact on an individual’s ability to participate. This definition of disability, therefore, goes beyond the medical and biophysical aspects to allow for the recognition that disability is a social and cultural construct. This highlights that without special attention to ensure there are no social, logistical, communication or education barriers to the provision of good and equitable health care for people with disabilities, they are at risk of poor health outcomes.

UNICEF clearly articulates the intersect between disability rights, health, and immunization, and highlights the inequity in access to immunization for children, young people, and adults with disabilities and the subsequent impact on their health and well-being.Citation15 Identifiable factors include inequitable access to health services, exclusion from health-care initiatives and a lack of understanding of the safety of immunization for those with underlying disability.Citation15 UNICEF highlights the need to better understand the factors that influence immunization practices for this population and to advocate for further research in this area.

Search strategy

The literature search aimed to identify any primary research on immunization in children, adolescents or adults with physical and/or intellectual disability with any underlying etiology present from early in life.

A list of search terms was compiled in discussion with a developmental pediatrician, accounting for the number of terms used to describe disability, and incorporating both broad descriptors and specific diagnoses, to ensure a comprehensive search of the disability literature (see ). These terms were paired with immunization search terms in order to find relevant articles through five databases: PubMed, CINAHL, ERIC, Embase, and Scopus. Reference lists of identified articles were searched for other relevant studies. Excluded were studies focusing on disability occurring post immunization, and immunization in adults with disabilities primarily due to aging. In total 28 studies were found (see ).

Table 1. Search terms.

Table 2. Summary of articles.

Results

The studies on immunization in people with a disability are characterized by the diverse settings, study design, disability type, and vaccinations included.

Disability type

Information was difficult to synthesize largely due to the variety of disability types. Some studies used specific diagnostic groups such as: those with inborn errors of metabolism,Citation16 ASD,Citation17 intellectual disability,Citation18Citation20 cerebral palsy,Citation3 and spina bifida.Citation21 Other studies used broad definitions of disability such as: children with special health-care needs (CSHCN),Citation22Citation24 women with physical disabilities,Citation25 youth attending specialist schools,Citation26,Citation27 children with neurological diseases, neurodevelopmental disorders, chronic neurological deficits or developmental disabilities,Citation28Citation32 and females with mental and physical limitations.Citation33

The issue with broad definitions is illustrated by two American studies which found no difference between immunization uptake for people with disabilities as compared to their typically developing peers. The first study measured uptake in a cohort of children with special health-care needsCitation34 and the second explored whether a medical model of care for children with special health care needs improved immunization rates.Citation24 The definition of “children with special health-care needs” is commonly used in USA, and includes children who require health or medical input above what would be typical, or any child on prescription medication or with emotional or behavioral disorders or chronic illness, as well including those with a disability.Citation35 Therefore “children with special health care needs” is too broad a definition to measure the difference in immunization uptake in the subpopulation of those with disability. Other studies from America have not replicated this finding with more specific populations for children with spina bifida,Citation21 autism,Citation36 and neurodevelopmental disorders.Citation32

Immunization coverage

The majority of the studies measured immunization uptake, with 18/28 (64%) calculating the uptake of one or more vaccinations in a population of people with disability.Citation3,Citation16,Citation18Citation23,Citation26Citation34,Citation37 The recognition of inequities in immunization services for vulnerable populations relies on the existence of disaggregate data.Citation38 Aggregate immunization uptake figures do not generally identify small populations at risk for under-immunizationCitation38 and therefore lower immunization coverage in people with disabilities can be missed. The studies suggested a likelihood of missed immunizations in people with disabilities, with 14/18 (78%) of the coverage studies finding that people with disabilities have lower rates of immunization uptake across a range of different vaccines then their typically developing peers.Citation3,Citation16,Citation18Citation23,Citation26Citation28,Citation30,Citation31,Citation33

Some studies measured immunization coverage indirectly. Three studies did not specifically explore a cohort of people with disabilities but instead found that disability predicted incomplete vaccination, including in girls in non-mainstream schools,Citation39 children with congenital malformations,Citation40 and Trisomy 21 and Autism Spectrum Disorders (ASD).Citation41 One study did not specifically investigate immunization coverage, but explored overall health service use among youth with ASD and found that they were less likely to receive immunizations.Citation17 Another assessed whether enhanced primary care in the form of a dedicated nurse practitioner to coordinate the child’s care improved immunization rates for children with special needsCitation24 and found that it did not. However, immunization uptake for children with disability in these practices was already above the national average prior to the intervention.Citation24

In addition to vaccine uptake, other studies aimed to explore the acceptability of HPV vaccine among women with physical disabilitiesCitation25 and provider recommendation for vaccines in a cohort of children with disability.Citation42 Two studies examined parental decision-making about vaccines after a diagnosis of ASD in their child.Citation36,Citation43 Both these studies concluded that parents were more likely to miss or delay immunizations after their child’s diagnosis of ASD, suggesting persisting concerns about the disproved link between vaccinations and autism.Citation36,Citation43 One study used grounded theory to explore the satisfaction of adults with ID with an immunization program.Citation44

Qualitative data

Although there were a few studies that aimed to determine barriers to immunization in people with a disability,Citation27,Citation30,Citation37 there was only one primary qualitative study to date.Citation44 This study explored the satisfaction of adults with ID with a program to immunize against Hepatitis B, with data collected directly from the individual with the disability rather than parents and/or care providers. This study used qualitative interviews from adult clients with intellectual disability and questionnaires with care staff to describe information in regards to the logistics of Hepatitis B delivery, use of restraint and information needed about immunization for this population. This level of analysis, not present in the other studies, allows an understanding of the experience of immunization and barriers to immunization that may inform meaningful, effective and equitable policies. Both in-depth qualitative research and the perspective of people with a disability is largely missing from research. This information is pivotal to understanding the barriers to uptake and the experience of immunization in this population.

Location of the research

The location also influences the definition and cultural understandings of disability and immunization policy and practice. The majority of studies were from the USA,Citation17,Citation21Citation24,Citation32,Citation34,Citation36,Citation43 with other high income countries represented, including Australia,Citation3,Citation27,Citation31,Citation40 Taiwan,Citation18Citation20,Citation25UK,Citation26,Citation39 Italy,Citation29,Citation30 France,Citation16 Ireland,Citation44 Canada,Citation41 JapanCitation42, and Switzerland.Citation28 Two studies were from low and middle income countries (LMICs). The first was a small study from Ecuador,Citation37 and the second was a cross-sectional study of families with children with chronic neurological conditions in Nigeria.Citation45

The Ecuadorian study was one of the four studies which found that children with disabilities did not have lower immunization rates than their typically developing peers. The authors suggested that the culture of the local society in valuing children with disabilities influenced immunization practices despite the poverty, isolated locations and difficulty accessing healthcare. This contrasts with the Nigerian study,Citation45 in which children with more obvious neurological deficits were less likely to be immunized. The environmental and cultural context is important in attitudes towards disability. More research in LMICs may improve our understanding of how different contexts impact health-care decision-making and act as a barrier to delivering equitable preventive health care for people with disability.

Age and types of vaccination

Only two studies include adults with disability,Citation25,Citation44 reflecting the weight of immunization research concentrating on childhood and adolescent funded vaccinations. The majority of research on childhood immunization focuses on a number of vaccines or the concept of being “up-to-date” with the current schedule. This contrasts with the studies on adolescent immunization, where five studies focus specifically on HPV immunization. These studies were divided between Australia,Citation27,Citation31 which offers a school-based immunization program for adolescent immunization, and the USA,Citation22,Citation23,Citation33 which offers adolescent vaccinations through local health-care providers. This is reflected in the lower rates of HPV uptake in the USA, but relative to their peers, adolescents with disabilities in all these studies had lower rates of initiating and completing the HPV course.

Acknowledging the need to optimize uptake of the HPV vaccine for young people with disabilities requires recognition that sexual health is important and relevant for this population. Indeed, one of the barriers that are reported by parents is that the HPV vaccination is “not needed”.Citation33 Other barriers to HPV acceptance are the lack of recommendation by a medical provider, and safety concerns. O’Neill et al.Citation27 also list reasons for non-vaccination for HPV, with the main reasons being absence from school, lack of consent and anxiety of the student. This study found no significant difference between dTPa and HPV uptake, suggesting that concerns about individual vaccines may be less of a barrier than logistical issues, which is a finding not previous explored for this population. The differences in barriers reported between these two studies may reflect the parent perspective as compared to the school perspective, establishing the value of multiple viewpoints.

Three studies specifically examine influenza immunization uptake for children and adolescents with disabilities.Citation18,Citation29,Citation32 Influenza is an annual immunization which is funded and recommended for at-risk groups in many countries. This includes people with impaired respiratory health, which is often present in children with cerebral palsy, epilepsy and other neurological conditions. Nevertheless, immunization rates in those with disabilities in all three studies are lower than, or similar to, the general population.Citation18,Citation29,Citation32

Provider recommendation

Several studies found that predictors of immunization in children with disabilities are were regular health checks,Citation18,Citation22 or recommendation to immunize by a health-care provider.Citation29,Citation33,Citation42 The importance of health-care provider recommendation is mirrored in the literature regarding interventions to improve confidence and uptake in immunizations in the general population.Citation46 Given this, the paucity of research exploring opinion and behavior of health professionals giving advice about immunizations to families with children with disabilities highlights the need for further exploration. Two studies included pediatrician perspectives on immunization as to whether they recommended vaccination in children with epilepsy or severe handicap.Citation42 It is unknown what beliefs and concerns other health professionals, such as GPs and immunization nurses, have about recommending vaccination to people with disability. This limits the current level of understanding of the many factors that may influence immunization decision-making, as well as the interventions that may be needed on a health professional level.

Conclusion

Drawing clear conclusions from the currently available research on immunization in people with disabilities is challenging, due to the different contexts, methodologies, definitions, age groups, and vaccines studied. Published studies are limited primarily to exploring immunization coverage in high-income settings. These knowledge gaps do not allow the development of strategies to ensure improved immunizations rates in this vulnerable population. Research is needed to develop a greater understanding of the barriers to immunization for people with disabilities and their families, including the perspective of people with disability and the advice and attitudes of health professionals and immunization providers. Immunization in people with disabilities is an important issue of both health and equity and deserves further research and discussion. Future research will provide opportunities to impact on the provider and parental attitudes and policy recommendations with a view to improving immunization rates in this population.

Disclosure of potential conflicts of interest

No potential conflicts of interest were disclosed.

Additional information

Funding

Jenny O’Neill was funded to undertake this research as part of a PhD with a Research and Training Stipend through The University of Melbourne, Melbourne; and the Developmental Disability and Rehabilitation Research Group Galli Trust through The Murdoch Research Institute, Melbourne; and a grant from DHHS Immunisation Section, Victoria.

References

  • WHO. 2016. Vaccination greatly reduces disease, disability, death and inequity worldwide. World Health Organisation; 2016 [accessed 2017 Jan 2]. Available from: http://www.who.int/bulletin/volumes/86/2/07-040089/en/.
  • Crowcroft NS, Hamid JS, Deeks SL, Frank J. Human papillomavirus vaccination programs reduce health inequity in most scenarios: a simulation study. BMC Public Health. 2012;12(1):935–43. doi:10.1186/1471-2458-12-935.
  • Greenwood VJ, Crawford NW, Walstab JE, Reddihough DS. Immunisation coverage in children with cerebral palsy compared with the general population. J Paediatr Child Heal. 2013;49(2):E137–E141. doi:10.1111/jpc.12097.
  • Cameron JC, Allan G, Johnston F, Finn A, Heath PT, Booy R. Severe complications of chickenpox in hospitalised children in the UK and Ireland. Arch Dis Child. 2007;22(12):1062–66. doi:10.1136/adc.2007.123232.
  • Sachedina N, Donaldson LJ. Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study. Lancet. 2010;376(9755):1846–52. doi:10.1016/S0140-6736(10)61195-6.
  • Ting A, Aniruddhan K, Hallam N, Freeman J, McFadzean J. Severe influenza in children with neurodevelopmental impairment - Implications for vaccination policy. J Infect. 2006;53:144–46. doi:10.1016/j.jinf.2005.10.025.
  • Blanton L, Peacock G, Cox C, Jhung M, Finelli L, Moore C. Neurologic disorders among pediatric deaths associated with the 2009 pandemic influenza. Pediatrics. 2012;130(3):390–96. doi:10.1542/peds.2011-3343.
  • Pérez-Padilla R, Fernández R, García-Sancho C, Franco-Marina F, Aburto O, López-Gatell H, Bojórquez I. Pandemic (H1N1) 2009 virus and Down syndrome patients. Emerg Infect Dis. 2010;16(8):1312–14. doi:10.3201/eid1608.091931.
  • Stark ZL, Buttery JP, Antolovich GC, Reddihough DS. The impact of influenza on children with disabilities. J Paediatr Child Health. 2004;40(5–6):332–332. doi:10.1111/j.1440-1754.2004.00389.x.
  • Blyth CC, Macartney KK, Hewagama S, Senenayake S, Friedman ND, Simpson G, Upham J, Kotsimbos T, Kelly P, Cheng AC. Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2014: the Influenza Complications Alert Network (FluCAN). Eurosurveillance. 2016;21(30):1–9. doi:10.2807/1560-7917.ES.2016.21.30.30301.
  • Dubé E, Leask J, Wolff B, Hickler B, Balaban V, Hosein E, Habersaat K. The WHO Tailoring Immunization Programmes (TIP) approach: review of implementation to date. Vaccine. 2018;36:1509–15. doi:10.1016/j.vaccine.2017.12.012.
  • Butler R, Macdonald NE. Diagnosing the determinants of vaccine hesitancy in specific subgroups: the guide to Tailoring Immunization Programmes (TIP) the SAGE Working Group on Vaccine Hesitancy. Vaccine. 2015;33:4176–79. doi:10.1016/j.vaccine.2015.04.038.
  • Kostanjsek N. Use of the International Classification of Functioning, disability and health (ICF) as a conceptual framework and common language for disability statistics and health information systems. BMC Public Health. 2011;11(Suppl 4):S3–S8. doi:10.1186/1471-2458-11-S4-S3.
  • World Health Organization. World report on disability. 2011. Available from: http://www.who.int/about/
  • Groce NE, Lang R Disability prevention efforts and disability rights: finding common ground on immunization efforts. 2012.
  • Cerutti M, De Lonlay P, Menni F, Parini R, Principi N, Esposito S. Vaccination coverage of patients with inborn errors of metabolism and the attitudes of their parents towards vaccines. Vaccine. 2015;33(48):6520–24. doi:10.1016/j.vaccine.2015.10.073.
  • Cummings JR, Lynch FL, Rust KC, Coleman KJ, Madden JM, Owen-Smith AA, Yau VM, Qian Y, Pearson KA, Crawford PM, et al. health services utilization among children with and without Autism Spectrum Disorders. J Autism Dev Disord. 2016;46(3):910–20. doi:10.1007/s10803-015-2634-z.
  • Yen C-F, Hsu S-W, Loh C-H, Fang W-H, Wu C-L, Chu CM, Lin J-D. Analysis of seasonal influenza vaccine uptake among children and adolescents with an intellectual disability. Res Dev Disabil. 2012;33:704–10. doi:10.1016/j.ridd.2011.11.011.
  • Yen CF, Lin JD. Factors influencing administration of hepatitis B vaccine to community-dwelling teenagers aged 12–18 with an intellectual disability. Res Dev Disabil. 2011;32(6):2943–49. doi:10.1016/j.ridd.2011.05.008.
  • Lin J-D, Lin P-Y, Lin L-P. Universal hepatitis B vaccination coverage in children and adolescents with intellectual disabilities. Res Dev Disabil. 2010;31:338–44. doi:10.1016/j.ridd.2009.09.005.
  • Raddish M. The immunization status of children with Spina Bifida. Arch Pediatr Adolesc Med. 1993;147(8):849. doi:10.1001/archpedi.1993.02160320051018.
  • McRee AL, Maslow GR, Reiter PL. Receipt of recommended adolescent vaccines among youth with special health care needs. Clin Pediatr (Phila). 2017;56(5):451–60. doi:10.1177/0009922816661330.
  • Cody PJ, Lerand SJ. HPV Vaccination in female children with special health care needs. J Pediatr Adolesc Gynecol. 2013;26:219–23. doi:10.1016/j.jpag.2013.03.003.
  • Samuels RC, Liu J, Sofis LA, Palfrey JS. Immunizations in children with special health care needs in a medical home model of care. Matern Child Health J. 2007 May 20;12(3):357–62. doi:10.1007/s10995-007-0241-0.
  • Yen C-F, Chen S-F, Lin L-P, Hsu S-W, Chang M-J, Wu C-L, Lin J-D. The acceptability of human papillomavirus (HPV) vaccination among women with physical disabilities. Res Dev Disabil. 2011;32(5):2020–26. doi:10.1016/j.ridd.2011.04.006.
  • Tuffrey C, Finlay F. Immunisation status amongst children attending special schools. Ambul Child Health. 2001;7(3–4):213–17. doi:10.1046/j.1467-0658.2001.00132.x.
  • O’Neill J, Newall F, Antolovich G, Lima S, Danchin M. The uptake of adolescent vaccinations through the school immunisation program in specialist schools in Victoria, Australia. Vaccine. 2019;37(2):272–79. doi:10.1016/j.vaccine.2018.11.034.
  • Tillmann BU, Tillmann HC, Heininger U, Lütschg J, Weber P. Acceptance and timeliness of standard vaccination in children with chronic neurological deficits in north-western Switzerland. Eur J Pediatr. 2005;164(5):320–25. doi:10.1007/s00431-005-1627-x.
  • Pandolfi E, Marino MG, Carloni E, Romano M, Gesualdo F, Borgia P, Carloni R, Guarino A, Giannattasio A, Tozzi AE. The effect of physician’s recommendation on seasonal influenza immunization in children with chronic diseases. BMC Public Health. 2012 Dec 15;12(1):984–91. doi:10.1186/1471-2458-12-984.
  • Pandolfi E, Carloni E, Marino MG, Ciofi Degli Atti ML, Gesualdo F, Romano M, et al. Immunization coverage and timeliness of vaccination in italian children with chronic diseases. Vaccine. 2012;30:5172–78.
  • O’Neill J, Elia S, Perrett K. Human Papillomavirus vaccine uptake in adolescents with developmental disabilities. J Intellect Dev Disabil. 2019;44(1):98–102. doi:10.3109/13668250.2017.1310827.
  • Smith M, Peacock G, Uyeki TM, Moore C. Influenza vaccination in children with neurologic or neurodevelopmental disorders. Vaccine. 2015;33:2322–27. doi:10.1016/j.vaccine.2015.03.050.
  • Rowe M, Pritt AL, Stratton AJ, Yoost JL. HPV Vaccination among females with mental and physical limitation. Marshall J Med. 2017;3:2. doi:10.18590/mjm.2017.vol3.iss2.8.
  • O ’Connor KS, Bramlett MD. Vaccination coverage by special health care needs status in young children what’s known on this subject. Pediatrics. 2008;1211(4):e768–e774. doi:10.1542/peds.2007-0305.
  • Bethell CD, Read D, Stein RK, Blumberg SJ, Wells N, Newacheck PW. Identifying children with special health care needs: development and evaluation of a short screening instrument. Ambulatory Pediatr. 2002;2(1):38–48. doi:10.1367/1539-4409(2002)002<0038:ICWSHC>2.0.CO;2.
  • Rosenberg RE, Law JK, Anderson C, Samango-Sprouse C, Law PA. Survey of vaccine beliefs and practices among families affected by autism spectrum disorders. Clin Pediatr (Phila). 2013 Sep;52(9):871.
  • Groce NE, Ayora P, Kaplan LC. Immunization rates among disabled children in ecuador: unanticipated findings. J Pediatr. 2007;151(2):218–20. doi:10.1016/j.jpeds.2007.04.061.
  • Boyce T, Gudorf A, Kat C, Muscat M, Butler R, Habersaat KB. Towards equity in immunisation. 2019;1–4 [accessed 2019 Mar 2]. Available from: www.eurosurveillance.org.
  • Fisher H, Audrey S, Mytton JA, Hickman M, Trotter C. Examining inequalities in the uptake of the school-based HPV vaccination programme in England: a retrospective cohort study. J Public Health (Bangkok). 2014;36(1):36–45. doi:10.1093/pubmed/fdt042.
  • Haynes K, Stone C. Predictors of incomplete immunisation in Victorian children. Aust N Z J Public Health. 2004;28:72–79.
  • Remes O, Smith LM, Alvarado-Llano BE, Colley L, Lévesque LE. Individual- and regional-level determinants of human papillomavirus (HPV) vaccine refusal: the Ontario Grade 8 HPV vaccine cohort study. BMC Public Health. 2014 Dec 8 cited 2016 Jul 31;14(1):1047. doi: 10.1186/1471-2458-14-1047.
  • Tanabe T, Tarawa T, Arai H, Imaishi H, Uno R, Tanaka J, Nagai T, Nishida M, Awaya Y, Maekawa K. Survey of Japanese pediatricians on vaccination of children with neurological disorders. Pediatr Int. 2011;53:626–29. doi:10.1111/j.1442-200X.2011.03339.x.
  • Bazzano A, Zeldin A, Schuster E, Barrett C, Lehrer D. Vaccine-related beliefs and practices of parents of children with Autism Spectrum Disorders. Am J Intellect Dev Disabil. 2012;117(3):233–42. doi:10.1352/1944-7558-117.3.233.
  • Cooney F. Patient satisfaction with a hepatitis B vaccination programme among persons with an intellectual disability. J Intellect Disabil. 2009;13(3):203–19. doi:10.1177/1744629509347227.
  • Okoro JC, Ojinnaka NC, Ikefuna AN, Onyenwe NE. Sociodemographic influences on immunization of children with chronic neurological disorders in Enugu, Nigeria. Trials Vaccinol. 2014;4:9–13. doi:10.1016/j.trivac.2014.11.002.
  • Wiley KE, Massey PD, Cooper SC, Wood NJ, Ho J, Quinn HE, Leask J. Uptake of influenza vaccine by pregnant women: a cross-sectional survey. Med J Aust. 2013 15;198(7):373–75.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.